Self-medication of migraine and tension-type headache: Summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG)

Journal of Headache and Pain

Volumn 12, Issue 2, 2011, Pages 201-217

  Haag, Gunther ^a   Diener, Hans Christoph ^b   May, Arne ^c   Meyer, Christian ^d   Morck, Hartmut ^e   Straube, Andreas ^f   Wessely, Peter ^g   Evers, Stefan ^h  

^a Michael Balint Klinik   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Neurology Practice   (Switzerland)

^e ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g Neurology Practice   (Austria)

^h UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Analgesics; Combined analgesics; Evidence based treatment recommendations; Fixed dose combinations; Migraine; Over the counter medication; Prescription free medication; Self medication; Tension type headache; Therapy guideline

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; CAFFEINE; CYCLANDELATE; DICLOFENAC; DIMENHYDRINATE; ELETRIPTAN; EXCEDRIN; IBUPROFEN; LITHIUM; MAGNESIUM; MELATONIN; NAPROXEN; NARATRIPTAN; OMEGA 3 FATTY ACID; PARACETAMOL; PEPPERMINT; PETASITES HYBRIDUS EXTRACT; PHENAZONE; PLACEBO; PROPYPHENAZONE; RIBOFLAVIN; RIZATRIPTAN; SODIUM; SUMATRIPTAN; THIOCTIC ACID; UBIDECARENONE;

CHRONIC TENSION HEADACHE; DRUG EFFICACY; EPISODIC TENSION HEADACHE; EVIDENCE BASED PRACTICE; HEALTH CARE ORGANIZATION; HUMAN; LAVENDER; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MONOTHERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SELF MEDICATION; SYSTEMATIC REVIEW; TENSION HEADACHE;

ANALGESICS; AUSTRIA; DRUG COMBINATIONS; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; MIGRAINE DISORDERS; SELF MEDICATION; SOCIETIES, MEDICAL; SWITZERLAND; TENSION-TYPE HEADACHE;

EID: 79958130995     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-010-0266-4     Document Type: Review

References (112)

1. Haag G, Evers S, May A, Neu IS, Vivell W, Ziegler A (2004) Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp. Evidenzbasierte Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG) [Self medication in migraine and tension-type headache - evidence-based treatment recommendations of the German Migraine and Headache Society]. Nervenheilkunde 23:415-430 (Pubitemid 39381860)
2. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edition (ICHD-II). Cephalalgia 24:S9-S160
3. Bellomo R, Bagshaw SM (2006) Evidence-based medicine: classifying the evidence from clinical trials - the need to consider other dimensions. Critical Care 10:232. doi:10.1186/cc5045
4. Chou R (2008) Using evidence in pain practice. Pain Med 9:518-541
5. Grimshaw J, Eccles M, Russell I (1995) Developing clinically valid practice guidelines. J Eval Clin Pract 1:37-48
6. Lundh A, Gøtzsche PC (2008) Recommendations by cochrane review groups for assessment of the risk of bias in studies. BMC Med Res Methodol 8:22. doi:10.1186/1471-2288-8-22
7. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB (2000) Evidence-based medicine-how to practice and teach EBM. Churchill Livingstone, Edinburgh
8. Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8:45. doi:10.1186/1471-2288-8-45
9. McDonald S, Antes G, Galandi D, Gøtzsche P, Hammarquist C, Haugh M, Jensen KL, Kleijnen J, Loep M, Pistotti V, Rüther A (2002) The contribution of handsearching European general health care journals to the Cochrane Controlled Trials Register. Eval Health Prof 25:65-75 (Pubitemid 34157784)
10. Bickley SR, Harrison JE (2003) How to ... find the evidence. J Orthodontics 30:72-78
11. Shekelle PG, Morton SC, Suttorp MJ, Buscemi N, Friesen C (2005) Challenges in systematic reviews of complementary and alternative medicine topics. Ann Intern Med 142:1042-1047 (Pubitemid 40847706)
12. Berger VW, Christophi CA (2003) Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. J Mod Appl Stat Methods 2:80-86 (Pubitemid 40665040)
13. European Agency for the Evaluation of Medicinal Products (EMEA) (1998) ICH Topic E 9 Statistical Principles for Clinical Trials. Step 5. Note for guidance on statistical principles for clinical trials. CPMP/ICH/363/96, Sep 1998
14. Juhl RP (1998) Prescription to over-the-counter switch: a regulatory perspective. Clin Therap 20(Suppl C):C111-C117
15. Berger VW, Weinstein S (2004) Ensuring the comparability of comparison groups: is randomization enough? Control Clin Trials 25:515-524 (Pubitemid 39299160)
16. Delgado-Rodriguez M, Llorca J (2004) Bias. J Epidemiol Community Health 58:635-641
17. Hamunen K, Kalso E (2005) A systematic review of trial methodology, using the placebo groups of randomized controlled trials in paediatric postoperative pain. Pain 116:146-158 (Pubitemid 40834322)
18. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12 (Pubitemid 26120810)
19. Kendall JM (2003) Designing a research project: randomised controlled trials and their principles. Emerg Med J 20:164-168
20. Reeves BC (2003) Principles of research: limitations of nonrandomized studies. Surgery 21:129-133
21. Schulz KF, Grimes DA (2005) Multiplicity in randomised trials I: endpoints and treatments. Lancet 365:1591-1595 (Pubitemid 40615409)
22. Macedo A, Farré M, Baños JE (2006) A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol 62:161-172 (Pubitemid 43357573)
23. Deeks JJ, Altman DG (1998) Inadequate reporting of controlled trials as short reports. Lancet 352:1908 (Pubitemid 28561259)
24. Rosmarakis ES, Soteriades ES, Vergidis PI, Kasiakou SK, Falagas ME (2005) From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J 19:673-680 (Pubitemid 40617372)
25. Evans M, Pollock A (1985) A score system for evaluating random control clinical trials of prophylaxis of abdominal surgical wound infection. Br J Surg 72:256-260 (Pubitemid 15090947)
26. Snow V, Weiss K, Wall EM, Mottur-Pilson C (2002) Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 137:840-849 (Pubitemid 35334454)
27. Silberstein SD, Rosenberg J (2000) Multispeciality consensus on diagnosis and treatment of headache. Neurology 54:1553 (Pubitemid 30226794)
28. Berman NG, Parker RA (2002) Meta-analysis: Neither quick nor easy. BMC Medical Res Methodol 2:(10)1-9
29. Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135:982-989
30. European Agency for the Evaluation of Medicinal Products (EMEA): points to consider on switching between superiority and non-inferiority. London, CPMP/EWP/482/99, July 2000
31. European Medicines Agency (EMEA): guideline on the choice of the non-inferiority margin. London, EMEA/CPMP/EWP/ 2158/99, July 2005
32. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B, Lipton RB (2009) Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics. Cephalalgia 29:188-193
33. Bigal ME, Bordini CA, Speciali JG (2002) Efficacy of three drugs in the treatment of migrainous aura: a randomized placebo- controlled study. Arqu Neuro-psiquiatr 60(2-B):406-409 (Pubitemid 34728735)
34. Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K (1999) Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur Neurol 42:173-179 (Pubitemid 29472100)
35. Danesch U, Rittinghausen R (2003) Safety of a patented special butterbur root extract for migraine prevention. Headache 43:76-78 (Pubitemid 36150996)
36. Diener HC, Rahlfs VW, Danesch U (2004) The first placebocontrolled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 51:89-97 (Pubitemid 38339722)
37. Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Göbel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller-Schwefe G, Nappi G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M (2004) EMSASI Study Group. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24:947-954 (Pubitemid 39471921)
38. Diener HC, Eikermann A, Gessner U, Göbel H, Haag G, Lange R, May A, Müller-Schwefe G, Voelker M (2004) Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 52:50-56 (Pubitemid 39077816)
39. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25:776-787 (Pubitemid 41368672)
40. Garcia-Ramos G, MacGregor EA, Hilliard B, Bordini CA, Leston J, Hettiarachchi J (2003) Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia 23:869-876 (Pubitemid 37352623)
41. Göbel H, Heinze A, Dworschak M, Heinze-Kuhn K, Stolze H (2004) Oleum menthae piperitae in der Akuttherapie von Migra ̈ne und Kopfschmerz vom Spannungstyp. Z Phytother 25:129-139 (Pubitemid 38878560)
42. Göbel H, Heinze A, Niederberger U, Witt T, Zumbroich V (2004) Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study. Cephalalgia 24:888-893 (Pubitemid 39319187)
43. Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, Battikha JP, Hoffman H, Baggish J (2005) Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache 45:973-982
44. Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebocontrolled study. Headache 46:444-453
45. Grigorova NA, Leshchenko OK (2003) Current aspects of the treatment of migraine. Likarska Sprava 5-6:80-85
46. Haas DC, Sheehe PR (2004) Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache. Headache 44:1029-1037 (Pubitemid 39532347)
47. Havanka H, Dahlöf C, Pop PH, Diener HC, Winter P, Whitehouse H, Hassani H (2000) Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Therap 22:970-980
48. Klassen A, Elkind A, Asgharnejad M, Webster C, Laurenza A (1997) Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group. Headache 37:640-645 (Pubitemid 28012113)
49. Kubitzek F, Ziegler G, Gold ML, Liu JMH, Ionescu E (2003) Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 7:155-162 (Pubitemid 36330533)
50. Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toor S, Northam RS, White LW, Lawson L (2002) Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 42:780-786 (Pubitemid 35291512)
51. Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A (2004) Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63:2240-2244 (Pubitemid 40024330)
52. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN (2005) Aspirin is efficacious for the treatment of acute migraine. Headache 45:283-292 (Pubitemid 40530192)
53. MacGregor EA, Dowson A, Davies PT (2002) Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study. Headache 42:249-255 (Pubitemid 34568895)
54. Massiou H, Jamin C, Hinzelin G, Bidaut-Mazel C (2005) The French Naramig Collaborative Study Group. Efficacy of oral Naratriptan in the treatment of menstrually related migraine. Eur J Neurol 12:774-781 (Pubitemid 41495134)
55. Mathew NT, Asgharnejad M, Peykamian M, Laurenza A, Naratriptan is effective, well tolerated in the acute treatment of migraine (1997) Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group. Neurology 49:1485-1490 (Pubitemid 28015105)
56. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT (1994) Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56:576-586 (Pubitemid 24370365)
57. Misra UK, Jose M, Kalita J (2004) Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial. Postgrad Med J 80:720-723 (Pubitemid 39627104)
58. Philipp M (1977) Therapy of migraine. Clinical experience with Migraeflux, a new migraine drug. Fortschr Med 95:107-110
59. Pothmann R, Danesch U (2005) Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache 45:196-203 (Pubitemid 40393207)
60. Saper J, Dahlöf C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, Barraclough E, Klipfel M, Lines C, Visser H, Reines S, Yuen E (2006) Rofecoxib Protocol 162 Study Group. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. Headache 46:264-275
61. Stark S, Spierings EL, McNeal S, Putnam GP, Bolden-Watson CP, O'Quinn S (2000) Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache 40:513-520 (Pubitemid 30497409)
62. Steiner TJ, Lange R (1998) Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: doubleblind placebo-controlled comparison with acetaminophen (1,000 mg). Cephalalgia 18:38-43 (Pubitemid 28096517)
63. Steiner TJ, Lange R, Voelker M (2003) Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 23:59-66
64. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P (2007) Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Ann Pharmacother 41:1782-1791
65. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, doubleblind, placebo-controlled trial. Headache 43:601-610 (Pubitemid 36828795)
66. Zukerman E, Negro MHS, Nothen MR (1990) Comparative study on the efficacy and tolerability of different formulations for Tonopan versus placebo in migraine. Rev Bras Neurol 26:57-60 (Pubitemid 20196065)
67. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, for the CONSORT group (2002) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663-694
68. Chan AW, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials-comparison of protocols to published articles. JAMA 291:2457-2465 (Pubitemid 38669189)
69. García-Berthou E, Alcaraz C (2004) Incongruence between test statistics and P values in medical papers. BMC Med Res Methodol 4:13. doi:10.1186/1471-2288-4-13
70. Gracely E (2008) So, why do I have to correct for multiple comparisons? Concepts and commentary on Turk et al. Pain 139:481-482
71. Turk DC, Dworkin RH, McDermott MP et al (2008) Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 139:485-493
72. Driscoll P, Lecky F, Crosby M (2000) An introduction to everyday statistics. Part 1. J Accid Emerg Med 17:205-211
73. Moher D, Dulberg CS, Wells GA (1994) Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272:122-124 (Pubitemid 24206043)
74. Halpern SD, Karlawish JHT, Berlin JA (2002) The continuing unethical conduct of underpowered clinical trials. JAMA 288:358-362 (Pubitemid 34761615)
75. Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 292:746-750 (Pubitemid 16167414)
76. Gehr BT, Weiss C, Porzsolt F (2006) The fading of reported effectiveness. A meta-analysis of randomised controlled trials. BMC Med Res Methodol 6:25. doi:10.1186/1471-2288-6-25
77. Pray WS (2006) Nonprescription medications and self care. Ethical, scientific, and educational concerns with unproven medications. Am J Pharm Educ 70(141):1-13
78. Farinelli I, Martelletti P (2007) Aspirin and tension-type headache. J Headache Pain 8:49-55 (Pubitemid 46443513)
79. Martelletti P, Farinelli I, Coloprisco G, Patacchioli FR (2007) Role of NSAIDs in acute treatment of headache. Drug Dev Res 68:276-281
80. Tfelt-Hansen P, Bjarnason NH, Dahlöf C, Derry S, Loder E, Massiou H, Task force on adverse events in migraine trials of the subcommittee on clinical trial of the International Headache Society (2008) Evaluation and registration of adverse events in clinical drug trials in migraine. Cephalalgia 28:683-688 (Pubitemid 351799757)
81. Evers S, May A, Fritsche G, Kropp P, Lampl C, Limmroth V, Malzacher V, Sandor P, Straube A, Diener HC (2008) Akuttherapie und Prophylaxe der Migräne - Leitlinie der Deutschen Migräne-und Kopfschmerzgesellschaft und der Deutschen Gesellschaft für Neurologie. Nervenheilkunde 27:933-949
82. Diener HC, Lampl C, Reimitz P, Voelker M (2006) Aspirin in the treatment of acute migraine attacks. Expert Rev Neurotherap 6:563-573 (Pubitemid 43764754)
83. Pageler L, Diener HC, Pfaffenrath V, Peil H, Aicher B (2009) Clinical relevance of efficacy endpoints in OTC trials. Headache 49:646-654
84. Bergmann JF (2003) Self-medication: from European regulatory directives to therapeutic strategy. Fundam Clin Pharmacol 17:275-280
85. Grossman M, Schmidramsl H (2000) An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 38:430-435
86. Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, Jayawardena S (2000) Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 40:561-567 (Pubitemid 30497414)
87. Hofmann R (2008) More to be said on "Triptans vs other drugs for acute migraine. Are there differences in efficacy?";. Headache 49:312-313
88. Glasser SP, Salas M, Delzell E (2007) Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems. J Clin Pharmacol 47:1074-1086
89. Moore N, Van Ganse E, Le Parc JM, Wall R, Schneid H, Farhan M, Verirere F, Pelen F (1999) The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. Clin Drug Invest 18:89-98
90. Andrade SE, Martinez C, Walker AM (1998) Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 51:1357-1365 (Pubitemid 29009538)
91. Feleppa M, Apice G, D'Alessio A, Fucci S, Bigal ME (2008) Tolerability of acute migraine medications: influence of methods of assessment and relationship with headache attributes. Cephalalgia 28:1012-1016
92. McQuay H, Moore A (1998) An evidence-based resource for pain relief. Oxford University Press, Oxford
93. West RR (2000) Evidence based medicine overviews, bulletins, guidelines, and the new consensus. Postgrad Med J 76:383-389
94. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298-301
95. Peikert A, Willimzig C, Kohne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16:257-263 (Pubitemid 26189252)
96. Pfaffenrath V, Wessely P, Meyer C, Isler H, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M (1996) Magnesium in the prophylaxis of migraine. A double-blind, placebo-controlled study. Cephalalgia 16:436-440 (Pubitemid 26338476)
97. Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, Burdine D, Manning P, Kabbouche MA (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47:73-80 (Pubitemid 46096060)
98. Rozen TD, OshinskyML, Gebeline CA, Bradley KC, YoungWB, Shechter AL, Silberstein SD (2002) Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 22:137-141 (Pubitemid 34494135)
99. Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713-715 (Pubitemid 40261904)
100. Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885-890 (Pubitemid 39362312)
101. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhäupl KM, Arnold G (2004) High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 11:475-477
102. Schoenen J, Lenaerts M, Bastings E (1994) High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 14:328-329
103. Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of highdose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466-470
104. Magis D, Ambrosini A, Sandor P, Jacquy J, Laloux P, Schoenen J (2007) A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 47:52-57 (Pubitemid 46096057)
105. Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille- Lafage G, Launay JM, Biason P (2001) Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a doubleblind study versus placebo. Cephalalgia 21:818-822 (Pubitemid 34621527)
106. Peres MFP, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J (2004) Melatonin, 3 mg, is effective for migraine prevention. Neurology 63:757 (Pubitemid 39100851)
107. Peres MF (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25:403-411
108. Peres MF, Masruha MR, Zukerman E, Moreira-Filho CA, Cavalheiro EA (2006) Potential therapeutic use of melatonin in migraine and other headache disorders. Exp Op Investig Drugs 15:367-375
109. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2006) The fixed combination of acetylsalicylic acid, paracetamol, and caffeine (reply). Cephalalgia 26:1087-1090
110. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, Wilkes K, Furey SA, Subramanian T, Cooper SA (2000) Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 20:233-243 (Pubitemid 32269494)
111. Lipton RB, Baggish S, Stewart WF, Codispoti JR, Fu M (2000) Efficacy and safety of acetaminophen in the treatment of migraine - results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med 160:3486-3492
112. Scher A, Lipton RN, Bigal M (2010) Response to 'Comments on results of Scher et al. pertaining to nonprescription caffeinecontaining combination analgesics'. Cephalalgia 30:1535-1536